60 results
6-K
EDAP
EDAP TMS S.A.
4 Mar 24
Current report (foreign)
8:15am
at six months. Results from the study also showed a positive safety profile with 96.7% of patients with no or non-significant adverse events (Clavien
6-K
EDAP
EDAP TMS S.A.
6 Jun 23
Current report (foreign)
8:00am
in developing HIFU beyond prostate cancer. We recently announced positive clinical results from the Phase 2 study evaluating the safety of therapeutic HIFU … of life and positive safety profile. Based on this positive safety and preliminary efficacy data, we intend to confirm the efficacy of the Focal One HIFU
6-K
EDAP
EDAP TMS S.A.
17 May 23
Current report (foreign)
6:35am
studies reconfirm safety and efficacy of Focal One -
- Company to host conference call and webcast today, Wednesday, May 17that 8:30 am EDT -
LYON … from these studies clearly demonstrate the safety, efficacy, and benefits of Focal One that support both continued growth and increased utilization
6-K
EX-1.1
0yp95qi0
26 Sep 22
Current report (foreign)
4:43pm
6-K
qe2td
9 Jun 22
Current report (foreign)
4:35pm
6-K
EX-1.1
rbhrzwsof5xpnl
26 Apr 21
Current report (foreign)
4:12pm
6-K
oak2pq
11 Jun 20
Current report (foreign)
4:35pm
6-K
EX-99.1
8hnxfkdktrqpcuwju6
30 Mar 20
EDAP Reports Record Full Year 2019 Results and Provides Operational Update
4:40pm